Morgan Stanley assumed coverage on shares of Merck KGaA (FRA: MRK) in a research note issued to investors on Thursday, Stock Ratings Network.com reports. The firm issued an overweight rating and a €142.00 ($184.42) price target on the stock.
Merck KGaA (FRA: MRK) traded up 0.61% on Thursday, hitting €123.05. Merck KGaA has a 1-year low of €72.51 and a 1-year high of €125.525. The stock’s 50-day moving average is currently €94.50.
A number of other firms have also recently commented on MRK. Analysts at AlphaValue reiterated a sell rating on shares of Merck KGaA in a research note to investors on Monday, May 20th. They now have a €108.00 ($140.26) price target on the stock. Separately, analysts at Commerzbank Corporates & Markets reiterated a reduce rating on shares of Merck KGaA in a research note to investors on Thursday, May 16th. They now have a €105.00 ($136.36) price target on the stock. Finally, analysts at Societe Generale reiterated a sell rating on shares of Merck KGaA in a research note to investors on Wednesday, May 15th. They now have a €101.00 ($131.17) price target on the stock.
Six investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus target price of €109.89 ($142.71).
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.